Want to see SMTI full AI Analyst Report?
Total Valuation
Sanara MedTech has a market cap or net worth of $316.53M. The enterprise value is $237.45.
Market Cap$316.53M
Enterprise Value$237.45
Share Statistics
Sanara MedTech has 9,188,035 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,188,035
Owned by Insiders41.26%
Owned by Institutions2.03%
Financial Efficiency
Sanara MedTech’s return on equity (ROE) is -6.33 and return on invested capital (ROIC) is 16.73%.
Return on Equity (ROE)-6.33
Return on Assets (ROA)-0.51
Return on Invested Capital (ROIC)16.73%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee954.80K
Profits Per Employee-256.08K
Employee Count108
Asset Turnover1.41
Inventory Turnover2.58
Valuation Ratios
The current PE Ratio of Sanara MedTech is ―. Sanara MedTech’s PEG ratio is -0.02.
PE Ratio―
PS Ratio1.95
PB Ratio33.96
Price to Fair Value33.96
Price to FCF93.17
Price to Operating Cash Flow52.41
PEG Ratio-0.02
Income Statement
In the last 12 months, Sanara MedTech had revenue of 103.12M and earned -37.56M in profits. Earnings per share was -4.36.
Revenue103.12M
Gross Profit92.94M
Operating Income9.15M
Pretax Income-393.12K
Net Income-37.56M
EBITDA9.03M
Earnings Per Share (EPS)-4.36
Cash Flow
In the last 12 months, operating cash flow was 5.69M and capital expenditures -1.19M, giving a free cash flow of 4.50M billion.
Operating Cash Flow5.69M
Free Cash Flow4.50M
Free Cash Flow per Share0.49
Dividends & Yields
Sanara MedTech pays an annual dividend of $33, resulting in a dividend yield of ―
Dividend Per Share$33
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.25
52-Week Price Change4.62%
50-Day Moving Average27.53
200-Day Moving Average22.75
Relative Strength Index (RSI)80.51
Average Volume (3m)61.65K
Important Dates
Sanara MedTech upcoming earnings date is Nov 16, 2026, Before Open (Confirmed).
Last Earnings DateAug 11, 2026
Next Earnings DateNov 16, 2026
Ex-Dividend Date―
Financial Position
Sanara MedTech as a current ratio of 1.80, with Debt / Equity ratio of 610.94%
Current Ratio1.80
Quick Ratio1.59
Debt to Market Cap0.23
Net Debt to EBITDA3.50
Interest Coverage Ratio1.35
Taxes
In the past 12 months, Sanara MedTech has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Sanara MedTech EV to EBITDA ratio is 25.80, with an EV/FCF ratio of 107.80.
EV to Sales2.26
EV to EBITDA25.80
EV to Free Cash Flow107.80
EV to Operating Cash Flow34.33
Balance Sheet
Sanara MedTech has $15.42M in cash and marketable securities with $48.53M in debt, giving a net cash position of -$33.11M billion.
Cash & Marketable Securities$15.42M
Total Debt$48.53M
Net Cash-$33.11M
Net Cash Per Share-$3.60
Tangible Book Value Per Share-$1.89
Margins
Gross margin is 91.33%, with operating margin of 8.87%, and net profit margin of -36.43%.
Gross Margin91.33%
Operating Margin8.87%
Pretax Margin-0.38%
Net Profit Margin-36.43%
EBITDA Margin8.76%
EBIT Margin6.17%
Analyst Forecast
The average price target for Sanara MedTech is $35.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$35.00
Price Target Upside36.93% Upside
Analyst ConsensusHold
Analyst Count3
Revenue Growth Forecast12.93%
EPS Growth Forecast-219.19%